[Asthenia in adolescents with attention deficit disorder and their treatment].
To study asthenia in adolescents with attention deficit hyperactivity disorder (ADHD) and assess the efficacy of nooclerin. We examined 60 patients, aged from 12 to 15 years, with ADHD. A comparative analysis of ADHD demonstrated the predominance of an inattentive type (ADHD-I) and a combined type (ADHD-C). Symptoms of asthenia were found in 56% of adolescents with ADHD-C and in 96.7% with ADHD-I. The high efficacy and safety of nooclerin in the treatment of ADHD was demonstrated. The improvement of mental state was achieved in 76.7% of patients with ADHD-I and in 53.3% patients with ADHD-C.